Table 2 Immunostaining of HAS1, HAS2 and HAS3 in human endometrium and its lesions
HAS1 staining intensity* | HAS2 staining intensity* | HAS3 staining intensity* | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epithelium | Stroma | Epithelium | Stroma | Epithelium | Stroma | |||||||||||
n.d. | weak | moderate | n.d. | weak | n.d. | weak | moderate | n.d. | weak | n.d. | weak | moderate | n.d. | weak | ||
Normal n = 10 | 4 | 2 (10-25%) | 4 (10-50%) | 7 | 3 (5-50%) | 7 | 3 (5-10%) | 0 | 8 | 2 (25%) | 5 | 5 (10-20%) | 0 | 9 | 1(10%) | |
Proliferating pm† n = 5 | 5 | 0 | 0 | 5 | 0 | 5 | 0 | 0 | 1 | 4 (5%) | 5 | 0 | 0 | 5 | 0 | |
Hyperplasia # n = 4 | 1 | 3 (5-25%) | 0 | 3 | 1 (10%) | 1 | 2 (10-25%) | 1 (50%) | 3 | 1 (10%) | 2 | 2 (10%) | 0 | 3 | 1(25%) | |
Grade 1 ‡ n = 8 | 0 | 5 (5-50%) | 3 (25-50%) | 6 | 2 (5%) | 2 | 5 (5-25) | 1 (50%) | 8 | 0 | 3 | 3 (5-25%) | 2 (25-50%) | 8 | 0 | |
Grade 2 + 3 ‡ n = 8 | 0 | 2 (25-50%) | 6 (5-50%) | 8 | 0 | 0 | 5 (5-50%) | 3 (5-50) | 7 | 1 (5%) | 0 | 3 (10-20%) | 5 (10-25%) | 8 | 0 | |